Abstract
Important considerations for effective cancer gene therapy are the targeted delivery of therapeutic genes and efficient endosomal escape of the genes in the cytoplasm. To address the first issues, target-specific aptamers and cationic lipids have been adopted for formulation of tumor-specific lipidic nanoparticles containing therapeutic genes. First of all we have developed EGF receptor (EGFR) aptamer-conjugated liposomes containing siRNA. The liposomal vehicles were optimized in terms of lipid constituents, ratio of lipid/siRNA, and aptamer conjugation process, and their biophysical characteristics were then determined by dynamic light scattering. Compared to the nonspecific cationic lipoplexes of siRNA, EGFR aptamer-conjugated liposomes encapsulating siRNA showed a relatively lower binding to EGFR-expressing cancer cells, resulting in a lower siRNA transfection. However, the EGFR aptamer-conjugated liposomes exhibited efficient transfection only to EGFR-expressing cancer cells, but not to EGFR-negative cancer cells. This research suggests that aptamer-conjugated lipidic nanoparticles can be utilized for target-specific delivery of therapeutic siRNAs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.